Merck KGaA MRK
Loading live quote…
$132.05
+17.15
(+14.93%)
Price Chart
About MERCK KGAA I
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt,…
Recent Quarters
| Quarter | Revenue | Net Income | EPS (dil.) | Gross Margin |
|---|---|---|---|---|
| 2026 Q1 | — | $-4,240,000,000 | -1.72 | 74.2% |
| 2025 Q4 | — | $2.96B | 1.19 | 66.2% |
| 2025 Q3 | — | $5.79B | 2.32 | 77.7% |
| 2025 Q2 | — | $4.43B | 1.76 | 77.5% |
MRK — Latest Coverage
